Susan Hasty, Publisher
Table of Contents . . . October 4th, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Drug Law Weekly | Other Publications
Collaborations - Aetna announces alliance with Standard Life for prescription drug plans
Generex Biotechnology Corp. - Buccal drug delivery company receives Australian patent
Healthcare Costs - Humana announces preferred pharmacy network
Inst. of Criminalistics & Criminology, Brussels - Researchers' findings advance diagnostics research
Lil' Drug Store Products, Inc. - Retailers scramble to provide safe, legal cold remedies
Medicare - Review of Medicare drug plans shows consumer choice lowers costs
Mergers & Acquisitions - Acquisition of PacifiCare positions UnitedHealth for Medicare growth
Mutual of Omaha - Insurance provider teams with Coventry to offer Medicare Part D plans
National Research Council of Canada - Microbes and products have potential in management of allergic asthma
ReGen Therapeutics Plc - Therapeutics company enters option agreement for zolpidem's new uses
Research Australia - BRAVE program provides help for children with anxiety
SkyePharma - Bronchodilator inhalation powder for asthma, COPD launched in Germany
Society of Gynecologic Oncologists - Gynecological oncology organization president testifies in support of H.R. 1245
Tobacco Use - Caron Foundation supports New Jersey's ban on smoking in dorms
Torchmark Corp. - United American gets Medicare Part D prescription drug plans approval from CMS
Academy Medical Center, Amsterdam - Triple-modality approach used to treat patients with cervical carcinoma
Ajou University, Suwon - Atherosclerotic patients should be divided for prognostic, therapeutic purposes
Alliance Pharmaceutical - Oxygent maker transfers assets of its subsidiary to MultiCell Technologies
Alnylam Pharmaceuticals - Pharma companies partner to discover therapeutics based on RNA interference
American Medical Association - High-dose radiation reduces risk of prostate cancer recurrence
Amgen - U.S. FDA expands Neulasta label
Amicus Therapeutics - Pharmacological chaperone developer raises $55M in financing
Amicus Therapeutics - Results study of Amigal for Fabry disease announced, phase II commences
Angiotech Pharmaceuticals - European approval granted for drug-eluting stent system
Antisoma - AS1404 lung cancer study reaches recruitment target
Berlex Biosciences - Findings in virology provide new insights
BioCryst Pharmaceuticals, Inc. - Phase II trial initiated for Fodosine in chronic lymphocytic leukemia
BioElectronics Corp. - Canadian health authorities clear pain patch for marketing
BioFocus - Deal signed for medicinal chemistry services
BioTime, Inc. - Aqueous-based synthetic solutions maker plans rights offering
Biomedical Primate Research Center, Rijswijk - Alternate priming approaches enhance hepatitis C vaccine in rhesus macaques
Blue Heron Biotechnology, Inc. - Gene synthesis company gets U.S. NIH grant for propagating difficult genes
Boston Scientific Corp. - Drug-eluting stent trials recognized as meeting ESC treatment guidelines
Bristol-Myers Squibb Company - U.S. FDA panel recommends approval of rheumatoid arthritis drug
British Medical Journal - Potential new treatment approach for severe asthma uncovered
British Nutrition Foundation - Integrated approach to tackling metabolic syndrome presented
CDC Foundation - Kaiser Permanente contributes $2 million for public health response to Katrina
CHU, Nantes - Administration of mylotarg yielded high rate of complete hematologic remission
Cardiology - Excluding deprivation from heart disease risk is jeopardizing thousands of lives
Celera Diagnostics - Diagnostics company extends collaboration with Merck in Alzheimer research
Center for Medical Parasitology, Copenhagen - Roles of Plasmodium mutations in chloroquine therapy examined
Chiba Cancer Center - Vinorelbine and gemcitabine used as third-line chemotherapy for refractory NSCLC
Chiba University - Reports describe recent advances in transplant medicine research
China Agriculture University - Procedure for large-scale preparation of plasmid DNA developed
Chinese Academy of Medical Sciences, Beijing - Muramyl dipeptide C augments hepatitis B therapy
Chinese Academy of Sciences, Shanghai - Andrographis paniculata component enhances leukocyte chemotaxis
Columbia University, New York - Method may provide effective, alternative treatment for coronary artery disease
Cornell University - Recent findings in hepatitis b therapy provide new insights
Cornell University, New York City - Celastrol has promise as a neuroprotective agent for treatment of PD, HD
Corvinus University of Budapest - Microbiological safety of two chilled meals improved by gamma irradiation
Cutting Edge Information - Makers of cancer therapies spend $85 million on marketing
DOR BioPharma Inc. - New data illuminates research in anthrax vaccines
Deutsche Forschungsgemeinschaft - DFG to fund nine clinical trials
Diabetes Complications - ACTOS reduces rate of heart attacks, strokes and death in type 2 diabetes
Elhuyar Fundazioa - Team aims to develop, evaluate antibacterial steel surfaces
Endovasc - Liprostin parent appoints new CFO
Erasme University Hospital - Immunostimulatory properties of dendritic cells examined
Fisher Biosciences - Biosciences company adds Cellomics technologies for cellular screening
Forbes Medi-Tech - IND application submitted for cholesterol-lowering drug, FM-VP4
Fourth Military Medical University - Studies advance knowledge in melanoma vaccines research
Fred Hutchinson Cancer Research Center, Seattle - Stem cell transplant survivors are as healthy as non-transplant patients
Gentium - Defibrotide maker to commence phase III trial following discussions with FDA
GlaxoSmithKline - GlaxoSmithKline announces U.S. FDA approval of Fluarix
Hospital JM Morales Meseguer, Murcia - Pneumonia severity associated with Legionella urinary antigen test
Impax Laboratories - Final U.S. FDA approval granted for generic version of Glucophage XR
MGI Pharma - U.S. FDA approvable letter issued for Dacogen (decitabine) injection
March of Dimes Birth Defects Foundation - Birth defect organization restates position on folic acid consumption
Merck & Co. - U.S. FDA approves Proquad, a one-shot MMR and chickenpox vaccine
Sodexho USA - Food services company makes switch to trans fat free products
Technical Sourcing International - New medicine for angina has same ingredient as MSV 60
Tufts Center for the Study of Drug Development - Study shows faster FDA approval has not increased drugs withdrawn due to safety
U.S. Food & Drug Administration - LC/MS/MS method to analyze chloramphenicol in crab meat developed
Verispan - Contract awarded to provide data to U.S. Food and Drug Administration
etrials Worldwide, Inc. - Clinical software company CEO Cline named 'inspiring person in life sciences'
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.